Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
This study has been completed.
Study NCT00019006 Information provided by National Cancer Institute (NCI)
First Received: March 1, 2007 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Colon Cancer
Stage III Pancreatic Cancer
Stage III Rectal Cancer
Recurrent Pancreatic Cancer
Recurrent Rectal Cancer
Stage I Pancreatic Cancer
Stage II Non-Small Cell Lung Cancer
Stage IVB Pancreatic Cancer
Stage II Pancreatic Cancer
Stage III Colon Cancer
Stage IVA Pancreatic Cancer
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Colonic Neoplasms
Lung Neoplasms
Pancreatic Neoplasms
Rectal Neoplasms
Recurrence
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Carcinoma, Neuroendocrine
Colonic Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Disease Attributes
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Pancreatic Diseases
Pathologic Processes
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
Detox-B adjuvant
ras peptide cancer vaccine
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
